Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | TBXAS1 | P24557 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5148219 | 0.96 | ALDH1A1 (0.68) | ALDH1A1KDM4ETBXAS1LMNAKMT2A | |
| SCHEMBL8387191 | 0.89 | TBXAS1 (0.59) | ALDH1A1KDM4ETBXAS1LMNAKMT2A | |
| SCHEMBL4425773 | 0.87 | TBXAS1 (0.60) | ALDH1A1KDM4ETBXAS1KMT2AMAPK1 | |
| SCHEMBL8386533 | 0.87 | LMNA (0.65) | ALDH1A1KDM4ETBXAS1LMNAKMT2A | |
| SCHEMBL8389532 | 0.86 | ALDH1A1 (0.60) | ALDH1A1KDM4ETBXAS1LMNAKMT2A | |
| SCHEMBL22268749 | 0.85 | TBXAS1 (0.66) | ALDH1A1KDM4ETBXAS1LMNAKMT2A | |
| SCHEMBL13007784 | 0.85 | ALDH1A1 (0.63) | ALDH1A1KDM4ETBXAS1KMT2AMAPK1 | |
| SCHEMBL13007775 | 0.85 | ALDH1A1 (0.63) | ALDH1A1KDM4ETBXAS1KMT2AMAPK1 | |
| SCHEMBL8387396 | 0.83 | TBXAS1 (0.62) | ALDH1A1KDM4ETBXAS1LMNAKMT2A | |
| SCHEMBL17859062 | 0.82 | ALDH1A1 (0.49) | ALDH1A1KDM4ETBXAS1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3587388-B1 | METHOD FOR PREPARING FLUORINATED METHACRYLATE COMPOUND | SAMHWA PAINTS IND CO LTD (KR) | 2023-08-16 | — | — | EP | claimed |
| EP-3546443-B1 | METHOD FOR PRODUCING FLUORINE-CONTAINING DIALKYL CARBONATE COMPOUNDS | SAMHWA PAINTS IND CO LTD (KR) | 2021-11-17 | — | — | EP | claimed |
| US-10889537-B2 | Method for producing fluorine-containing dialkyl carbonate compounds | SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) | 2021-01-12 | — | — | US | claimed |
| US-10752574-B2 | Method for preparing fluorinated methacrylate compound | SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) | 2020-08-25 | — | — | US | claimed |
| US-20200231530-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING DIALKYL CARBONATE COMPOUNDS | SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) | 2020-07-23 | — | — | US | claimed |
| EP-3546443-A2 | METHOD FOR PRODUCING FLUORINE-CONTAINING DIALKYL CARBONATE COMPOUNDS | Samhwa Paints Industries Co., Ltd. (KR) | 2019-10-02 | — | — | EP | claimed |
| US-4532268-A | Imidazole agent for retarding the polymerization of aziridine compounds | ESPE, FABRIK PHARMAZEUTISCHER PRAPARATE GMBH (DE) | 1985-07-30 | — | — | US | claimed |
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-17 | — | — | US | disclosed |
| EP-3883522-B1 | USE OF A POLYETHER-MODIFIED POLYDIMETHYL SILOXANE FOR REDUCING THE STICKINESS OF A DENTAL IMPRESSION COMPOSITION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-01-08 | — | — | EP | disclosed |
| US-20240285476-A1 | DENTAL COMPOSITION COMPRISING AN ISORBIDE COMPONENT | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-08-29 | — | — | US | disclosed |
| EP-4346741-A1 | DENTAL COMPOSITION COMPRISING AN ISORBIDE COMPONENT | Solventum Intellectual Properties Company (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-117813334-A | Onium salt, blocking agent dissociation catalyst for blocking isocyanate, blocked isocyanate composition containing blocking agent dissociation catalyst, thermosetting resin composition, cured product, and method for producing same | 广荣化学株式会社 | 2024-04-02 | — | — | CN | disclosed |
| CN-117642404-A | Small molecule modulators of glucocerebrosidase activity and uses thereof | 凡况生化公司 | 2024-03-01 | — | — | CN | disclosed |
| EP-0110429-A2 | Retarders for the polymerisation of aziridine compounds | ESPE Stiftung & Co Produktions- und Vertriebs KG (DE) | 1984-06-13 | — | — | EP | disclosed |
| US-4450277-A | Preparation of 1-substituted imidazoles | BASF AKTIENGESELLSCHAFT (DE) | 1984-05-22 | — | — | US | disclosed |
| EP-0003560-B1 | IMIDAZOLE DERIVATIVES AND SALTS THEREOF, THEIR SYNTHESIS, AND PHARMACEUTICAL FORMULATIONS | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-05-02 | — | — | EP | disclosed |
| US-4416895-A | ANTICOAGULANTS, ANTISHOCK AGENTS | BURROUGHS WELLCOME CO. (US) | 1983-11-22 | — | — | US | disclosed |
| EP-0026908-B1 | PROCESS FOR PREPARING 1-SUBSTITUTED IMIDAZOLES | BASF Aktiengesellschaft (DE) | 1983-06-22 | — | — | EP | disclosed |
| EP-0026908-A1 | Process for preparing 1-substituted imidazoles | BASF Aktiengesellschaft (DE) | 1981-04-15 | — | — | EP | disclosed |
| EP-0003560-A2 | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations | THE WELLCOME FOUNDATION LIMITED (GB) | 1979-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10889537-B2 | Method for producing fluorine-containing dialkyl carbonate compounds | CA3, CDA, CHKB | ALDH1A1 2228/4885KDM4E 650/4885TBXAS1 2714/4885 |
| US-20200231530-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING DIALKYL CARBONATE COMPOUNDS | CA3, GK, CLK3 | ALDH1A1 2737/4885KDM4E 2108/4885TBXAS1 3199/4885 |
| US-20240285476-A1 | DENTAL COMPOSITION COMPRISING AN ISORBIDE COMPONENT | INTS9, PUF60, TAS2R42 | ALDH1A1 2914/4885KDM4E 680/4885TBXAS1 3950/4885 |
| US-10752574-B2 | Method for preparing fluorinated methacrylate compound | MMAB, ALKBH5, MEP1A | ALDH1A1 35/4885KDM4E 271/4885TBXAS1 1254/4885 |
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KDM2B, O60361, IDH3B | ALDH1A1 1023/4885KDM4E 194/4885TBXAS1 1184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.